The efficacy and safety of SARS-CoV-2 vaccines mRNA1273 and BNT162b2 might be complicated by rampant C-to-U RNA editing

被引:0
|
作者
Zhongzheng Bian
Ziqian Wu
Nan Liu
Xiao Jiang
机构
[1] The Affiliated Hospital of Qingdao University,Department of Emergency Medicine
[2] The Affiliated Hospital of Qingdao University,Department of Emergency Intensive Care Unit
来源
关键词
SARS-CoV-2; Vaccines; Synonymous codon usage; C-to-U RNA editing; Efficacy;
D O I
暂无
中图分类号
学科分类号
摘要
The SARS-CoV-2 RNA vaccines are smartly designed to increase the synonymous codon usage by introducing multiple U-to-C mutations. This design would elevate the translation efficiency of vaccine RNAs. However, we found evidence to reason that the designed cytidines might be converted to uridines again by C-to-U RNA deamination in host cells. This C-to-U mechanism might be a main factor that affects the efficacy and safety of RNA vaccines.
引用
收藏
页码:361 / 365
页数:4
相关论文
共 50 条
  • [41] Systemic and Mucosal Humoral Immune Response Induced by Three Doses of the BNT162b2 SARS-CoV-2 mRNA Vaccines
    Mancuso, Roberta
    Agostini, Simone
    Citterio, Lorenzo Agostino
    Chiarini, Debora
    Santangelo, Maria Antonia
    Clerici, Mario
    VACCINES, 2022, 10 (10)
  • [42] Comparison of cytokine production in mice inoculated with messenger RNA vaccines BNT162b2 and mRNA-1273
    Nakayama, Tetsuo
    Sawada, Akihito
    Ito, Takeshi
    MICROBIOLOGY AND IMMUNOLOGY, 2023, 67 (03) : 120 - 128
  • [43] Role of booster with BNT162b2 mRNA in SARS-CoV-2 vaccination in patients with rheumatoid arthritis
    Benucci, Maurizio
    Damiani, Arianna
    Li Gobbi, Francesca
    Lari, Barbara
    Grossi, Valentina
    Infantino, Maria
    Manfredi, Mariangela
    IMMUNOLOGIC RESEARCH, 2022, 70 (04) : 493 - 500
  • [44] Role of booster with BNT162b2 mRNA in SARS-CoV-2 vaccination in patients with rheumatoid arthritis
    Maurizio Benucci
    Arianna Damiani
    Francesca Li Gobbi
    Barbara Lari
    Valentina Grossi
    Maria Infantino
    Mariangela Manfredi
    Immunologic Research, 2022, 70 : 493 - 500
  • [45] BNT162b2 and mRNA-1273 COVID-19 vaccine effectiveness against the SARS-CoV-2 Delta variant in Qatar
    Patrick Tang
    Mohammad R. Hasan
    Hiam Chemaitelly
    Hadi M. Yassine
    Fatiha M. Benslimane
    Hebah A. Al Khatib
    Sawsan AlMukdad
    Peter Coyle
    Houssein H. Ayoub
    Zaina Al Kanaani
    Einas Al Kuwari
    Andrew Jeremijenko
    Anvar Hassan Kaleeckal
    Ali Nizar Latif
    Riyazuddin Mohammad Shaik
    Hanan F. Abdul Rahim
    Gheyath K. Nasrallah
    Mohamed Ghaith Al Kuwari
    Hamad Eid Al Romaihi
    Adeel A. Butt
    Mohamed H. Al-Thani
    Abdullatif Al Khal
    Roberto Bertollini
    Laith J. Abu-Raddad
    Nature Medicine, 2021, 27 : 2136 - 2143
  • [46] Innate immune responses to three doses of the BNT162b2 mRNA SARS-CoV-2 vaccine
    Saresella, Marina
    Piancone, Federica
    Marventano, Ivana
    Hernis, Ambra
    Trabattoni, Daria
    Invernizzi, Mattia
    La Rosa, Francesca
    Clerici, Mario
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [47] Antibody responses to the BNT162b2 mRNA vaccine in individuals previously infected with SARS-CoV-2
    Ebinger, Joseph E.
    Fert-Bober, Justyna
    Printsev, Ignat
    Wu, Min
    Sun, Nancy
    Prostko, John C.
    Frias, Edwin C.
    Stewart, James L.
    Van Eyk, Jennifer E.
    Braun, Jonathan G.
    Cheng, Susan
    Sobhani, Kimia
    NATURE MEDICINE, 2021, 27 (06) : 981 - +
  • [48] Antibody responses to the BNT162b2 mRNA vaccine in individuals previously infected with SARS-CoV-2
    Joseph E. Ebinger
    Justyna Fert-Bober
    Ignat Printsev
    Min Wu
    Nancy Sun
    John C. Prostko
    Edwin C. Frias
    James L. Stewart
    Jennifer E. Van Eyk
    Jonathan G. Braun
    Susan Cheng
    Kimia Sobhani
    Nature Medicine, 2021, 27 : 981 - 984
  • [49] Trajectory of IgG to SARS-CoV-2 After Vaccination With BNT162b2 or mRNA-1273 in an Employee Cohort and Comparison With Natural Infection
    Keshavarz, Behnam
    Richards, Nathan E.
    Workman, Lisa J.
    Patel, Jaimin
    Muehling, Lyndsey M.
    Canderan, Glenda
    Murphy, Deborah D.
    Brovero, Savannah G.
    Ailsworth, Samuel M.
    Eschenbacher, Will H.
    McGowan, Emily C.
    Mann, Barbara J.
    Nelson, Michael R.
    Kadl, Alexandra
    Woodfolk, Judith A.
    Platts-Mills, Thomas A. E.
    Wilson, Jeffrey M.
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [50] Humoral and cellular response to SARS-CoV-2 BNT162b2 mRNA vaccine in hemodialysis patients
    Melin, Jan
    Svensson, Maria K.
    Albinsson, Bo
    Winqvist, Ola
    Pauksens, Karlis
    BMC IMMUNOLOGY, 2021, 22 (01)